DF9-24462-64605
3 vaccinations
4 coded responses
36 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 860 / AZ
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Moderna
-
2021-01-27
Survey response — day 0, dose 1MedDRA: Chest discomfort, Hypoaesthesia, Paraesthesia — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessFree text: Tightness in chest and tingling/numb sensation in vaccinated armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-03
- 2021-02-10
- 2021-02-18
-
2021-02-24
Dose 2 — Moderna
- 2021-02-24
-
2021-02-25
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Bruising at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to workAdult check-in
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-02
- 2021-03-03
- 2021-03-10
- 2021-03-18
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-05-26
-
2021-08-25
Survey response — 6 months, dose 2MedDRA: Heavy menstrual bleeding, Intermenstrual bleeding, Menstrual disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Abnormal menstruation (spotting between periods; weeks-long periods)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-25
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-12-03
- 2021-12-08
-
2021-12-12
Dose 3 — Pfizer-BioNTech
-
2021-12-13
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-12-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-12-15
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-12-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-12-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-12-21
- 2021-12-26
- 2022-01-02
- 2022-01-09
- 2022-01-16
- 2022-01-23
- 2022-03-13
- 2022-06-12
-
2022-12-13
Survey response — 12 months, dose 3MedDRA: Hypertension, Pre-eclampsia, Protein urine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Preeclampsia (high blood pressure and protein in urine); inductionMedDRA releases: 2024-11 · check-in free text available
-
2022-12-13
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-12-14
- 2022-12-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-02-24 | Moderna | |
| 3 | 2021-12-12 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Tightness in chest and tingling/numb sensation in vaccinated arm
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Bruising at injection site
Release 9 — 6 months, dose 2
Symptoms: Abnormal menstruation (spotting between periods; weeks-long periods)
Release 12 — 12 months, dose 3
Symptoms: Preeclampsia (high blood pressure and protein in urine); induction
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Heavy menstrual bleeding | ✓ | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Intermenstrual bleeding | ✓ | · | ✓ |
| SD | Menstrual disorder | ✓ | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Protein urine | · | · | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release